Built at Home: India’s Advanced Biotech Ecosystem
1. Why it matters India carries a disproportionate share of the world’s genetic disease burden, including one of the largest populations living with sickle cell disease, thalassemia, and other inherited blood disorders, alongside a fast-rising cancer caseload. The global gene-editing and cell-therapy industry, meanwhile, has produced treatments priced in the millions of dollars, out of […]
Built at Home: India’s Advanced Biotech Ecosystem Read More »